FDA Inspection
Midlab IncorporatedMidlab Incorporated – FDA Inspection, Sep 13, 2024
Record Details
This FDA Inspection record concerns Midlab Incorporated, with an inspection on September 13, 2024, issued by the New Orleans District Office, covering human drugs.
View Company Profile
ID · f07226d6-b3a6-47ec-a0ac-ec50891d98a9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1249514
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.165(f)Failing drug products not rejected
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Midlab Incorporated
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 5, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 14, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Midlab Incorporated
- FDA Inspection 1177708 - 2022-08-05
- FDA Inspection 1021846 - 2017-05-24
- FDA Inspection 767524 - 2012-02-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.